RCEL (AVITA Medical) PB Ratio: (As of Jun. 25, 2026)


RCEL AVITA Medical Inc RCEL
66 GF Score
Price $3.95
GF Value $10.78
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), AVITA Medical's share price is $3.95. AVITA Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $-0.75. Hence, AVITA Medical's PB Ratio of today is .

The historical rank and industry rank for AVITA Medical's PB Ratio or its related term are showing as below:

During the past 13 years, AVITA Medical's highest PB Ratio was 264.63. The lowest was 1.17. And the median was 5.59.

RCEL's PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.04
* Ranked among companies with meaningful PB Ratio only.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AVITA Medical was 212.10% per year. The lowest was -66.70% per year. And the median was -20.90% per year.

Back to Basics: PB Ratio


AVITA Medical  (NAS:RCEL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AVITA Medical PB Ratio Related Terms


AVITA Medical PB Ratio Historical Data

* Premium members only.

The historical data trend for AVITA Medical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVITA Medical PB Ratio Chart

AVITA Medical Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.42 1.96 7.18 74.85 0.00

AVITA Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RCEL vs NNOX, MXCT, SNWV: PB Ratio Comparison

For the Medical Devices subindustry, AVITA Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's PB Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's PB Ratio falls into.


RCEL
66GF Score
AVITA Medical Inc RCEL
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AVITA Medical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AVITA Medical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=3.95/-0.753
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is AVITA Medical (RCEL) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of $3.95 is trading 63.4% below its estimated GF Value™ of $10.78. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for RCEL:

  • PB Ratio:
  • GF Value™: $10.78 vs. price of $3.95 (63.4% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the RCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
66GF Score

Get the complete analysis for RCEL

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95
Price
$10.78
GF Value